Lidocaine/Adrenaline/Tetracaine

利多卡因/肾上腺素/丁卡因

Report date: 2026/02/13 10:40:19

Base Information

Drug NameLidocaine/Adrenaline/Tetracaine
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionAdrenergic receptors agonistsRyanodine receptor 2 modulatorsRyanodine receptor 1 modulators
TargetsSodium channel alpha subunitAdrenergic receptorsRyanodine receptor 2 +[4] 
Therapy Area/IndicationsLacerations
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes LidocaineAdrenalineTetracaine
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesChildren'S Hospital Of Orange County
China Registration ClassN/A

Develop Information

Active CompaniesChildren'S Hospital Of Orange County
Inactive CompaniesN/A
Active IndicationsLacerations
Inactive IndicationsN/A

Other Information

ATC CodeN01BA53
Related LinksN/A